Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Shailendra Kumar Gautam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8959-1331; OpenAlex author ID A5112855030. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
54
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 6 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 15

  1. A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer. Co-author DOI 10.1016/j.actbio.2026.04.026↗
  2. Acinar cell plasticity and subtype specification during acinar-to-ductal metaplasia and pancreatic cancer progression. Co-author DOI 10.1016/j.bbcan.2026.189549↗
  3. Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer. Co-author DOI 10.1038/s41698-025-01046-w↗
  4. Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-023-01813-y↗
  5. Endothelin-axis antagonism enhances tumor perfusion in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215801↗
  6. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling. Co-author DOI 10.1016/j.ebiom.2021.103772↗
  7. Regulation of pancreatic cancer therapy resistance by chemokines. Co-author DOI 10.1016/j.semcancer.2022.08.010↗
  8. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-022-02493-6↗
  9. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion. Co-author DOI 10.1158/1541-7786.mcr-21-0888↗
  10. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Co-author DOI 10.7150/thno.64805↗
  11. Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β. Co-author DOI 10.1002/jbm.a.37080↗
  12. Modeling pancreatic cancer in mice for experimental therapeutics. First author DOI 10.1016/j.bbcan.2021.188554↗
  13. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Co-author DOI 10.1016/j.smim.2020.101391↗
  14. Emerging trends in the immunotherapy of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.12.012↗
  15. MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/14728222.2017.1323880↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maneesh Jain · 14 shared papers, 2017–2026 · strength 2.12
  2. Surinder K. Batra · 13 shared papers, 2017–2026 · strength 1.94
  3. Sushil Kumar K · 6 shared papers, 2017–2022 · strength 0.64
  4. Balaji Narasimhan · 4 shared papers, 2018–2026 · strength 0.56
  5. Joyce C. Solheim · 4 shared papers, 2018–2026 · strength 0.56
  6. Moorthy Palanimuthu Ponnusamy · 4 shared papers, 2022–2025 · strength 0.56
  7. Sanjib Chaudhary · 3 shared papers, 2022–2026 · strength 0.55
  8. Luman Liu · 3 shared papers, 2021–2026 · strength 0.49
  9. Rakesh Bhatia · 3 shared papers, 2017–2026 · strength 0.47
  10. Namita Bhyravbhatla · 3 shared papers, 2022–2025 · strength 0.45
  11. Parthasarathy Seshacharyulu · 3 shared papers, 2022–2025 · strength 0.43
  12. Kavita B. Mallya · 3 shared papers, 2021–2022 · strength 0.41
  13. Aliasger K Salem · 2 shared papers, 2022–2026 · strength 0.37
  14. Satyanarayana Rachagani · 3 shared papers, 2022 · strength 0.35
  15. Pranita Atri · 3 shared papers, 2022 · strength 0.35
  16. Rama Krishna Nimmakayala · 3 shared papers, 2022 · strength 0.35
  17. Bharti Gautam · 1 shared paper, 2026 · strength 0.33
  18. Ramesh Pothuraju · 1 shared paper, 2026 · strength 0.33
  19. Kasturi Banerjee · 2 shared papers, 2018–2026 · strength 0.31
  20. Sakthivel Muniyan · 2 shared papers, 2022 · strength 0.24
  21. Sanchita Rauth · 2 shared papers, 2022 · strength 0.24
  22. Imayavaramban Lakshmanan · 2 shared papers, 2022 · strength 0.24
  23. Ashu Shah · 2 shared papers, 2022 · strength 0.24
  24. Saravanakumar Marimuthu · 2 shared papers, 2022 · strength 0.24
  25. Lynette M. Smith · 2 shared papers, 2022 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.